Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

33.12USD
24 Apr 2015
Change (% chg)

$-0.38 (-1.13%)
Prev Close
$33.50
Open
$33.41
Day's High
$33.64
Day's Low
$33.06
Volume
409,820
Avg. Vol
--
52-wk High
$45.45
52-wk Low
$28.26

Search Stocks
LAWRENCE DAVID
Trading Date Type Shares Traded Price Shares Held
3 Mar 2015 Buy 5,573 $0.00 16,619
17 Dec 2014 Sell 27,109 $40.11 11,046
17 Dec 2014 Buy 27,109 $8.14 11,046
30 Nov 2014 Sell 8,898 $35.60 11,046
6 Oct 2014 Sell 250 $33.60 19,944
4 Mar 2014 Buy 6,000 $0.00 20,194
1 Dec 2013 Sell 10,836 $33.51 14,194
6 Oct 2013 Buy 1,000 $0.00 25,030

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 252
Total Shares Held: 45,105,196
3 Mo. Net Change: -64,790
# New Positions: 6
# Closed Positions: 1
# Increased Positions: 14
# Reduced Positions: 9
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

Ron Cohen

58 President,Chief Executive Officer, Director

Michael Rogers

54 2013 Chief Financial Officer

Lauren Sabella

53 2010 Executive Vice President - Commercial Development

Andrew Blight

63 2004 Chief Scientific Officer

Jane Wasman

57 2012 President - International, General Counsel, Corporate Secretary

Enrique Carrazana

53 2011 Chief Medical Officer

Andrew Asa Hindman

2014 Chief Business Development Officer

David Lawrence

56 2013 Chief - Business Operations

Barry Greene

51 2007 Independent Director

Peder Jensen

59 2011 Independent Director

John Kelley

60 2008 Independent Director

Sandra Panem

67 1998 Independent Director

Lorin Randall

70 2006 Independent Director

Steven Rauscher

60 2005 Independent Director

Ian Smith

49 2007 Independent Director
Search Stocks